SEC Form 3 · accession 0001127602-18-020501
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Derica W Rice
Officer — EVP & President, CVS Caremark
Period of report
Jun 4, 2018
Accepted (ET)
Jun 8, 2018 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 7,887 | D | ||
| Common Stock (pep)F1 | holding | — | — | — | 7,887 | D | ||
| Common Stock (restricted)F2 | holding | — | — | — | 23,663 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF3 | $62.21 | holding | — | — | — | Apr 1, 2019 | Apr 1, 2025 | Common Stock | 116,767 | — | D |
| Stock OptionF4 | $63.39 | holding | — | — | — | May 31, 2021 | May 31, 2028 | Common Stock | 78,870 | — | D |
Explanation of responses
- F1Consists of matching Restricted Stock Units awarded pursuant to Issuer's Partnership Equity Program, under its 2017 Incentive Compensation Plan. Restrictions lapse 5/31/2023.
- F2Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 5/31/2019.
- F3Option becomes exercisable in four equal annual installments, commencing 4/1/2019.
- F4Option becomes exercisable in three equal annual installments, commencing 5/31/2021.